These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4119480)

  • 1. [Hyperfibrinogemia following activator therapy].
    Zawilska K; Jazienicki B
    Acta Haematol Pol; 1972; 3(1):53-8. PubMed ID: 4119480
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypofibrinolysis in acute myocardial infarction (author's transl)].
    Bruhn HD; Jipp P; Okoye S; Oltmann A
    Med Klin; 1974 Nov; 69(47):1951-5. PubMed ID: 4444662
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenformin plus ethyloestrenol in survivors of myocardial infarction. Three-year pilot study.
    Chakrabarti R; Fearnley GR
    Lancet; 1972 Sep; 2(7777):556-9. PubMed ID: 4115736
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic study of fibrinogen and its split products in venous thrombosis.
    Sova J
    Acta Univ Carol Med Monogr; 1972; 52():173-9. PubMed ID: 4593289
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinolytic activity and coronary-artery disease.
    Chakrabarti R; Hocking ED; Fearnley GR; Mann RD; Attwell TN; Jackson D
    Lancet; 1968 May; 1(7550):987-90. PubMed ID: 4171834
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombolytic therapy with streptokinase.
    Chesterman CN; Biggs JC
    Med J Aust; 1970 Oct; 2(18):839-46. PubMed ID: 4923084
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombolytic therapy in acute myocardial infarct and pulmonary artery thromboembolism].
    Iakovlev VB; Gospodarenko AL; Makarenko AS
    Voen Med Zh; 1993 Jun; (6):45-7. PubMed ID: 8367952
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fibrinolytics. 46].
    Wagler M
    Pharm Prax; 1970; 6():141-2. PubMed ID: 4195438
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lysis of thrombi and emboli by means of streptokinase. I. Activation of fibrinolysis, mechanism of plasmin activity, indications and contra-indications, treatment principles].
    Janda R; Cencora A; Uzieblo W
    Przegl Lek; 1969; 25(10):701-5. PubMed ID: 4242965
    [No Abstract]   [Full Text] [Related]  

  • 10. Streptokinase therapy in acute myocardial infarction.
    Nissen MB
    Heart Lung; 1984 May; 13(3):223-30. PubMed ID: 6370913
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease.
    Fearnley GR; Chakrabarti R; Hocking ED
    Lancet; 1967 Nov; 2(7524):1008-11. PubMed ID: 4168522
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticoagulation.
    Chong BH
    Aust Fam Physician; 1996 Jan; 25(1):74-8. PubMed ID: 8607780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolytic activity and coronary-artery disease.
    Naimi S; Proger S
    Lancet; 1968 Jun; 1(7554):1250-1. PubMed ID: 4172804
    [No Abstract]   [Full Text] [Related]  

  • 14. Laboratory assessment of thrombolytic therapy in acute myocardial infarction.
    Talalak P; Chaithiraphan S; Opartkiattikul N; Leowattana W; Sangtawesin W; Tresukosol D
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():144-8. PubMed ID: 7886558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombolytic medication. Theoretical and practical aspects].
    Săvulescu V; Litarczek G
    Med Interna (Bucur); 1973 Sep; 25(9):1103-12. PubMed ID: 4792530
    [No Abstract]   [Full Text] [Related]  

  • 17. [When is fibrinolytic therapy indicated?].
    Woitinas F
    Med Klin; 1980 Feb; 75(3):98-107. PubMed ID: 6990218
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of fibrinolysin with heparin and thrombolytin on blood coagulation indices in myocardial infarct patients with thromboembolic complications].
    Panchenko VM; Dmitrieva ZA; Pastorova VE
    Ter Arkh; 1971 Aug; 43(8):95-9. PubMed ID: 4261359
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical use of heparin.
    Engelberg H
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 Pt1):34-44. PubMed ID: 808389
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
    Menon IS
    Acta Univ Carol Med Monogr; 1972; 52():19-23. PubMed ID: 4669824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.